Literature DB >> 8709796

Fludarabine treatment and transfusion-associated graft-versus-host disease.

L M Williamson, J Z Wimperis, M E Wood, B Woodcock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8709796     DOI： 10.1016/S0140-6736(05)64563-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  A SHOT in the arm for safer blood transfusion.

Authors:  L M Williamson; J Heptonstall; K Soldan
Journal:  BMJ       Date:  1996-11-16

Review 2.  Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.

Authors:  J C Adkins; D H Peters; A Markham
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 3.  A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation.

Authors:  James L Gajewski; Viviana V Johnson; S Gerald Sandler; Antoine Sayegh; Thomas R Klumpp
Journal:  Blood       Date:  2008-06-26       Impact factor: 22.113

4.  Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.

Authors:  Andrea Boni; Pawel Muranski; Lydie Cassard; Claudia Wrzesinski; Chrystal M Paulos; Douglas C Palmer; Luca Gattinoni; Christian S Hinrichs; Chi-Chao Chan; Steven A Rosenberg; Nicholas P Restifo
Journal:  Blood       Date:  2008-09-17       Impact factor: 22.113
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.